Envoy Medical, Inc. COCH
Industrial Specialties · IPO 2021 · data as of November 13, 2026
Envoy Medical, Inc. (COCH) is a healthcare company listed in the US with a market value of about $52M. In the twelve months to September 30, 2026 it had revenue of $231000 and net income of -$21M, a net margin of -9026.4%.
Its overall Stock Analiz score is 1.2 out of 5 (weak). The strongest part is value (2/5); the weakest is future growth (1/5).
Key numbers: a P/E of 0.9, a 5-year average ROIC of -1128%.
About Envoy Medical
Envoy Medical is listed in the US and classified in industrial specialties, IPO year 2021. Revenue went from $237000 in 2022 to $241000 in 2025, growth of about 0.6% a year. It was profitable in 0 of the last 5 years in our data. Its share count rose by 130% over three years (dilution for shareholders). It spends 5181% of revenue on research and development.
Score: 1.2 / 5
Checks passed
- P/E below 25
- P/E below the industry median
- Strong R&D investment or growth above 20%
- ROE above 15%
- More cash than debt, or low debt to equity
- Pays a dividend
Checks not passed
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- Profit margin improving
- 3-year free cash flow growth above 10% a year
- 5-year EPS growth above 10% a year
Valuation
Growth and quality
Financials, last 5 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue | $231000 | $241000 | $225000 | $316000 | $237000 | — |
| Net income | -$21M | -$24M | -$21M | -$30M | -$16M | -$251633 |
| Free cash flow | -$22M | -$18M | -$19M | -$17M | -$9M | — |
| EPS (diluted) | $7.84 | $-1.23 | $-1.49 | $-2.54 | $-1.57 | — |
| Net margin | -9026.4% | -9857.3% | -9242.2% | -9469.0% | -6718.6% | — |
| ROIC | — | — | — | -1127.8% | — | — |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
Frequently asked questions
What is Envoy Medical’s P/E ratio?
About 0.9, based on the last twelve months of diluted earnings per share.
Does Envoy Medical pay a dividend?
Yes. The dividend yield is about 3.49%, and it has paid dividends for 2 years in our data.
Is Envoy Medical a good stock to buy?
We do not give buy or sell advice. Envoy Medical scores 1.2 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.